Deferasirox prevents progression of non-alcoholic steatohepatitis in a mouse model with inhibition of heaptic fibrosis and hepatocellular ballooning

被引：0
|
作者：
Korenaga, Masaaki [1 ]
Korenaga, Keiko [1 ]
Mizokami, Masashi [1 ]
Kanto, Tatsuya [1 ]
机构：
[1] Natl Ctr Global Hlth & Med NCGM Kohnodai, Res Ctr Hepstitis & Immunol, Ichikawa, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1583
引用
收藏
页码：785A / 786A
页数：2
相关论文
共 50 条
  • [31] Zeaxanthin reduces fibrosis in a gerbil model of non-alcoholic steatohepatitis
    Chamberlain, Sherman M.
    Bartoli, Manuela
    Rodriguez, Nancy
    Lee, Jeffrey R.
    Patel, Jigneshkumar
    Sridhar, Subbaramiah
    Marcus, Dennis M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S222 - S223
  • [32] Hepatocytic ballooning in non-alcoholic steatohepatitis: Dilemmas and future directions
    Li, Yang-Yang
    Zheng, Tian-Lei
    Xiao, Shu-Yuan
    Wang, Peng
    Yang, Wen-Jun
    Jiang, Li-Lin
    Chen, Li-Li
    Sha, Jun-Cheng
    Jin, Yi
    Chen, Sui-Dan
    Byrne, Christopher D.
    Targher, Giovanni
    Li, Jian-Min
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2023, 43 (06) : 1170 - 1182
  • [33] Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model
    Takegoshi, Kai
    Honda, Masao
    Okada, Hikari
    Takabatake, Riuta
    Matsuzawa-Nagata, Naoto
    Campbell, Jean S.
    Nishikawa, Masashi
    Shimakami, Tetsuro
    Shirasaki, Takayoshi
    Sakai, Yoshio
    Yamashita, Taro
    Takamura, Toshinari
    Tanaka, Takuji
    Kaneko, Shuichi
    ONCOTARGET, 2017, 8 (11) : 18191 - 18205
  • [34] Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model
    Takegoshi, Kai
    Honda, Masao
    Okada, Hikari
    Matsuzawa, Naoto
    Takabatake, Hisashi
    Takamura, Toshinari
    Tanaka, Takuji
    Kaneko, Shuichi
    HEPATOLOGY, 2014, 60 : 638A - 638A
  • [35] Non-alcoholic steatohepatitis-associated hepatic fibrosis and hepatocellular carcinoma in a combined mouse model of genetic modification and dietary challenge
    Amano, Yuichiro
    Shimizu, Fumi
    Yasuno, Hironobu
    Harada, Ayako
    Tsuchiya, Shuntarou
    Isono, Osamu
    Nagabukuro, Hiroshi
    Tozawa, Ryuichi
    HEPATOLOGY RESEARCH, 2017, 47 (01) : 103 - 115
  • [36] Lack of Osteopontin promotes non-alcoholic steatohepatitis (NASH) and fibrosis, but protects against hepatocellular carcinoma (HCC) progression and mortality in a NASH-HCC mouse model
    Nardo, A. D.
    Gruen, N. G.
    Zeyda, M.
    Oberhuber, G.
    Dumanic, M.
    Helbich, T.
    Stulnig, T. M.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S680 - S681
  • [37] Reduction of Polyunsaturated Fatty Acids with Tumor Progression in a Lean Non-Alcoholic Steatohepatitis-Associated Hepatocellular Carcinoma Mouse Model
    Vlock, Elizabeth M.
    Karanjit, Shilpa
    Talmon, Geoffrey
    Farazi, Paraskevi A.
    JOURNAL OF CANCER, 2020, 11 (19): : 5536 - 5546
  • [38] AGING PROMOTES HEPATOCELLULAR STEATOSIS, INFLAMMATION AND FIBROSIS IN NON-ALCOHOLIC STEATOHEPATITIS IN MICE
    Saugspier, M.
    Dorn, C.
    Hellerbrand, C.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S498 - S498
  • [39] Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model
    Hayashida, Momoka
    Hashimoto, Kei
    Ishikawa, Tomoko
    Miyamoto, Yasunori
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2019, 100 (02) : 72 - 82
  • [40] Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma
    Antonio Cuadrado
    Aitor Orive
    Covadonga García-Suárez
    Agustín Domínguez
    Jose Carlos Fernández-Escalante
    Javier Crespo
    Fernando Pons-Romero
    Obesity Surgery, 2005, 15 : 442 - 446
12345